Dear Doctor: Is it true that people with alcohol addiction can get help by taking GLP-1 drugs?
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Dr. Roach: A GLP-1 agonist can help reduce weight, sleep apnea and more
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Lohud.com, Westchester County on MSN6dOpinion
GLP-1 drugs should require eating disorder screening before prescription | Opinion
By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...
Your Good Health: A GLP-1 agonist can help reduce weight, sleep apnea and more
He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned about ...
BioSpace5d
GLP-1 Players Seek to Differentiate in Increasingly Crowded Weight Loss Space
As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...
Fierce Biotech4d
Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic
The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...
Medscape1d
How Can Doctors Help Patients Navigate Wild Online Market for Compounded GPL-1 Drugs?
GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...
Seeking Alpha1d
Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate
an oral GLP-1R agonist, shows potential in obesity treatment, with significant Phase 2 data expected in Q4 2025. Despite a crowded GLP-1 drug development field, Structure's oral small molecule ...
BioSpace3d
OPKO and Entera Link Up to Advance First Oral GLP-1/Glucagon Drug Into Clinic
Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.